These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 30105813

  • 1. MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma.
    Chen J, Yu Y, Chen X, He Y, Hu Q, Li H, Han Q, Ren F, Li J, Li C, Bao J, Ren Z, Duan Z, Cui G, Sun R.
    Cell Prolif; 2018 Dec; 51(6):e12510. PubMed ID: 30105813
    [Abstract] [Full Text] [Related]

  • 2. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
    Zheng X, Zhou Y, Chen W, Chen L, Lu J, He F, Li X, Zhao L.
    Cell Physiol Biochem; 2018 Dec; 51(3):1340-1353. PubMed ID: 30481782
    [Abstract] [Full Text] [Related]

  • 3. Oviductus ranae protein hydrolysate (ORPH) inhibits the growth, metastasis and glycolysis of HCC by targeting miR-491-5p/PKM2 axis.
    Xu Q, Dou C, Liu X, Yang L, Ni C, Wang J, Guo Y, Yang W, Tong X, Huang D.
    Biomed Pharmacother; 2018 Nov; 107():1692-1704. PubMed ID: 30257387
    [Abstract] [Full Text] [Related]

  • 4. LDHA is a direct target of miR-30d-5p and contributes to aggressive progression of gallbladder carcinoma.
    He Y, Chen X, Yu Y, Li J, Hu Q, Xue C, Chen J, Shen S, Luo Y, Ren F, Li C, Bao J, Yan J, Qian G, Ren Z, Sun R, Cui G.
    Mol Carcinog; 2018 Jun; 57(6):772-783. PubMed ID: 29569755
    [Abstract] [Full Text] [Related]

  • 5. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
    Jia G, Wang Y, Lin C, Lai S, Dai H, Wang Z, Dai L, Su H, Song Y, Zhang N, Feng Y, Tang B.
    J Exp Clin Cancer Res; 2021 Sep 22; 40(1):299. PubMed ID: 34551796
    [Abstract] [Full Text] [Related]

  • 6. Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer.
    Chen J, Yu Y, Li H, Hu Q, Chen X, He Y, Xue C, Ren F, Ren Z, Li J, Liu L, Duan Z, Cui G, Sun R.
    Mol Cancer; 2019 Mar 02; 18(1):33. PubMed ID: 30825877
    [Abstract] [Full Text] [Related]

  • 7. MIR210HG regulates glycolysis, cell proliferation, and metastasis of pancreatic cancer cells through miR-125b-5p/HK2/PKM2 axis.
    Yu T, Li G, Wang C, Gong G, Wang L, Li C, Chen Y, Wang X.
    RNA Biol; 2021 Dec 02; 18(12):2513-2530. PubMed ID: 34110962
    [Abstract] [Full Text] [Related]

  • 8. miR-625-5p/PKM2 negatively regulates melanoma glycolysis state.
    Zhang H, Feng C, Zhang M, Zeng A, Si L, Yu N, Bai M.
    J Cell Biochem; 2019 Mar 02; 120(3):2964-2972. PubMed ID: 30500994
    [Abstract] [Full Text] [Related]

  • 9. MiR-4733-5p promotes gallbladder carcinoma progression via directly targeting kruppel like factor 7.
    Hu X, Zhang J, Bu J, Yang K, Xu S, Pan M, Xiang D, Chen W.
    Bioengineered; 2022 Apr 02; 13(4):10691-10706. PubMed ID: 35443866
    [Abstract] [Full Text] [Related]

  • 10. miR-361-5p modulates metabolism and autophagy via the Sp1-mediated regulation of PKM2 in prostate cancer.
    Ling Z, Liu D, Zhang G, Liang Q, Xiang P, Xu Y, Han C, Tao T.
    Oncol Rep; 2017 Sep 02; 38(3):1621-1628. PubMed ID: 29094170
    [Abstract] [Full Text] [Related]

  • 11. miR-324-5p inhibits gallbladder carcinoma cell metastatic behaviours by downregulation of transforming growth factor beta 2 expression.
    Zhang X, Zhang L, Chen M, Liu D.
    Artif Cells Nanomed Biotechnol; 2020 Dec 02; 48(1):315-324. PubMed ID: 31858815
    [Abstract] [Full Text] [Related]

  • 12. miR-188-5p inhibits proliferation, migration, and invasion in gallbladder carcinoma by targeting Wnt2b and Smad2.
    Li XL, Li SZ, Wu CX, Xing XH.
    Kaohsiung J Med Sci; 2021 Apr 02; 37(4):294-304. PubMed ID: 33236530
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7.
    Ye YY, Mei JW, Xiang SS, Li HF, Ma Q, Song XL, Wang Z, Zhang YC, Liu YC, Jin YP, Hu YP, Jiang L, Liu FT, Zhang YJ, Hao YJ, Liu YB.
    Cell Death Dis; 2018 Mar 14; 9(3):410. PubMed ID: 29540696
    [Abstract] [Full Text] [Related]

  • 14. CircPHGDH downregulation decreases papillary thyroid cancer progression through miR-122-5p/PKM2 axis.
    Shen J, Ma Z, Yang J, Qu T, Xia Y, Xu Y, Zhou M, Liu W.
    BMC Cancer; 2024 Apr 23; 24(1):511. PubMed ID: 38654205
    [Abstract] [Full Text] [Related]

  • 15. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer.
    Guo M, Zhao X, Yuan X, Jiang J, Li P.
    Oncotarget; 2017 Apr 25; 8(17):28226-28236. PubMed ID: 28415668
    [Abstract] [Full Text] [Related]

  • 16. Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p.
    Goeppert B, Truckenmueller F, Ori A, Fritz V, Albrecht T, Fraas A, Scherer D, Silos RG, Sticht C, Gretz N, Mehrabi A, Bewerunge-Hudler M, Pusch S, Bermejo JL, Dietrich P, Schirmacher P, Renner M, Roessler S.
    Sci Rep; 2019 Mar 18; 9(1):4796. PubMed ID: 30886199
    [Abstract] [Full Text] [Related]

  • 17. PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells.
    Yao A, Xiang Y, Si YR, Fan LJ, Li JP, Li H, Guo W, He HX, Liang XJ, Tan Y, Bao LY, Liao XH.
    J Cell Biochem; 2019 Apr 18; 120(4):6542-6554. PubMed ID: 30368881
    [Abstract] [Full Text] [Related]

  • 18. Down-Regulated miR-125a-5p Promotes the Reprogramming of Glucose Metabolism and Cell Malignancy by Increasing Levels of CD147 in Thyroid Cancer.
    Huang P, Mao LF, Zhang ZP, Lv WW, Feng XP, Liao HJ, Dong C, Kaluba B, Tang XF, Chang S.
    Thyroid; 2018 May 18; 28(5):613-623. PubMed ID: 29634399
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway.
    Shu YJ, Bao RF, Jiang L, Wang Z, Wang XA, Zhang F, Liang HB, Li HF, Ye YY, Xiang SS, Weng H, Wu XS, Li ML, Hu YP, Lu W, Zhang YJ, Zhu J, Dong P, Liu YB.
    Cell Death Differ; 2017 Mar 18; 24(3):445-457. PubMed ID: 28060377
    [Abstract] [Full Text] [Related]

  • 20. Up-regulation of PKM2 promote malignancy and related to adverse prognostic risk factor in human gallbladder cancer.
    Lu W, Cao Y, Zhang Y, Li S, Gao J, Wang XA, Mu J, Hu YP, Jiang L, Dong P, Gong W, Liu Y.
    Sci Rep; 2016 Jun 10; 6():26351. PubMed ID: 27283076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.